Search results

Jump to navigation Jump to search
Results 1 – 185 of 185
Advanced search

Search in namespaces:

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  • 0218_files/flexiweigh_balance_accuracy.pdf Scales - TripSit wiki  3-MeO-PCP - TripSit wiki  Responsible drug use index
    5 KB (1,438 words) - 23:18, 21 April 2024
  • Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    6 KB (1,847 words) - 00:06, 16 May 2024
  • important compounds such as hormones like melatonin and the neurotransmitter serotonin (5-hydroxytryptamine). Many psychoactive tryptamines have been found to
    10 KB (461 words) - 23:05, 21 April 2024
  • info - Home  https://psychonautwiki.org/wiki/File:Behandeling-4-fa-intoxicatie.pdf https://psychonautwiki.org/wiki/File:4-FA%20risicobeoordeling%20(2016)
    21 KB (3,439 words) - 15:42, 30 July 2022
  • combine it with other MAOIs, stimulants and certain substances which release serotonin or dopamine. It is recommended to avoid blends or branded products if the
    19 KB (2,209 words) - 23:08, 21 April 2024
  • In order to maintain consistency across the wiki, images of molecular structures should be produced in a standardized format rather than obtained from
    19 KB (857 words) - 09:55, 15 September 2022
  • 1371/journal.pone.0194984. ISSN 1932-6203.  3-MeO-PCE (TripSit) | https://wiki.tripsit.me/wiki/3-MeO-PCE https://www.zakonyprolidi.cz/cs/2013-463?text=o+seznam
    20 KB (2,787 words) - 17:34, 17 March 2024
  • ISSN 0378-4274.  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp
    26 KB (4,063 words) - 23:35, 21 April 2024
  • acids such as tryptophan, while in humans this amino acid is used to make serotonin. The result is that some of the tryptamines in nature are serotonergic
    70 KB (630 words) - 04:11, 16 May 2024
  • (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-M
    25 KB (3,130 words) - 14:33, 16 April 2024
  • Melatonin ⋅ Neuron ⋅ Neurotransmitter ⋅ Noradrenaline ⋅ Receptor ⋅ SerotoninSerotonin syndrome ⋅ Substance P ⋅ Synapse Dreams ⋅ Dream characters ⋅ Dream
    21 KB (1,004 words) - 23:38, 13 May 2024
  • its effects by promoting the release of serotonin, dopamine, and norepinephrine in the brain, particularly serotonin. MDMA was first developed in 1912 by
    85 KB (10,499 words) - 14:24, 16 April 2024
  • ISSN 0378-4274.  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp
    28 KB (4,417 words) - 14:00, 16 April 2024
  • Tripsitting index (category PsychonautWiki)
    following page using our guidelines.   The Tripsitting Index is a collection of wiki articles designed to serve as a comprehensive reference work for the diverse
    905 bytes (619 words) - 20:57, 24 April 2023
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    33 KB (4,870 words) - 14:34, 16 April 2024
  • It produces its effects by increasing levels of the neurotransmitters serotonin, dopamine, and norepinephrine in the brain. Methamphetamine was first synthesized
    41 KB (5,798 words) - 13:29, 16 April 2024
  • (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-M
    18 KB (2,543 words) - 21:36, 21 July 2022
  • ISSN 0378-4274.  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp
    19 KB (3,278 words) - 19:48, 19 July 2022
  • 0218_files/flexiweigh_balance_accuracy.pdf Scales - TripSit wiki  3-MeO-PCP - TripSit wiki  Ask Erowid : ID 2282 : How big is a milligram?  Erowid Psychoactives
    9 KB (1,092 words) - 23:18, 21 April 2024
  • toxicity by the serotonin 2A receptor partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    36 KB (4,745 words) - 16:35, 7 April 2024
  • produces its effects by increasing levels of dopamine, norepinephrine, and serotonin in the brain. 4-FMA was first detected being sold in Japan as a legal high
    21 KB (3,467 words) - 16:14, 30 July 2022
  • Ecstasy Testing Kit FAQ (Erowid) Colorimetric reagent results (DMT-Nexus Wiki) How to Reagent Test guide (Reddit) Test results for all drugs & substances
    23 KB (1,192 words) - 17:50, 19 March 2024
  • into it. MDMA: 3-MeO-PCP acts as a mild serotonin releasing agent and could interact negatively with the serotonin release of MDMA Austria: 3-MeO-PCP is
    25 KB (3,520 words) - 21:44, 6 May 2024
  • contain alkaloids. Some amines, such as the monoamines adrenaline and serotonin, which play an important role in higher animals, are similar to alkaloids
    10 KB (1,117 words) - 13:15, 12 October 2020
  • http://www.americanweigh.com/pdf/manuals/gemini-20_manual.pdf 3-MeO-PCP - TripSit wiki  Erowid Psychoactive Vaults : Liquid Measurement Technique  Erowid. "25I-NBOMe
    37 KB (3,944 words) - 23:17, 21 April 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    23 KB (3,267 words) - 23:45, 21 April 2024
  • complete hallucinations. It is thought to produce its effects by binding to serotonin receptors in the brain, although the precise mechanism is not fully understood
    58 KB (7,681 words) - 22:15, 14 May 2024
  • this substantion. It can get up to around 2.5-3 points on the psychonaut wiki scale. (click Traces above to read more) Transformations - This effect occurs
    41 KB (5,610 words) - 19:01, 7 April 2024
  • similarity to the serotonin molecule. It has a higher affinity than serotonin itself for the receptors, therefore preventing serotonin from binding to the
    31 KB (3,363 words) - 22:58, 21 April 2024
  • Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    27 KB (1,991 words) - 18:31, 18 September 2022
  • methylphenidate). Some stimulants also have an additional significant effect on serotonin, such as MDMA, MDA, and methylone; these substances are sometimes separately
    11 KB (1,055 words) - 02:52, 12 May 2024
  • inhibitors (NDRIs) Selective serotonin reuptake inhibitors (SSRIs) Serotonin and norepinephrine reuptake inhibitors (SNRIs) Serotonin antagonist and reuptake
    9 KB (1,069 words) - 21:47, 13 May 2024
  • and inhibits serotonin reuptake while the S- enantiomer inhibits noradrenaline reuptake. Tramadol acts as an opioid receptor agonist, serotonin releasing
    22 KB (3,211 words) - 19:11, 7 April 2024
  • the mu receptors with serotonin, dopamine, and norepinephrine. Activation of mu receptors allows for the disinhibition of serotonin and dopamine neurons
    19 KB (2,797 words) - 02:47, 12 May 2024
  • increase or modulate serotonin such as MDMA and Monoamine Oxidase Inhibitors (MAOIs). A combination with these substances can lead to serotonin syndrome and potentially
    15 KB (1,687 words) - 18:59, 22 November 2023
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (2,841 words) - 14:21, 16 April 2024
  • chemical similarities with the neurotransmitter serotonin, which enables it to interact with a range of serotonin receptor sites throughout the brain that are
    40 KB (4,715 words) - 16:45, 25 January 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,590 words) - 21:20, 30 April 2024
  • ratio for dopamine and serotonin indicated mephedrone was preferentially a serotonin releaser, with a ratio of 1.22:1 (serotonin vs. dopamine). Additionally
    29 KB (3,963 words) - 14:23, 16 April 2024
  • releasing agent of the main three monoamines; serotonin, norepinephrine, and dopamine, and as a non-selective serotonin receptor agonist. αMT's psychedelic effects
    25 KB (2,825 words) - 16:14, 28 November 2022
  • to work, as the DMT molecule (which is a monoamine closely related to serotonin) is rendered almost entirely inactive when digested by itself due to the
    33 KB (3,884 words) - 07:33, 16 November 2023
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    31 KB (4,379 words) - 12:23, 6 May 2024
  • 2C-T-2 (category PsychonautWiki articles needing factual verification from October 2020)
    [citation needed] this could indicate that 2C-T-2 is more likely to induce serotonin syndrome or general neurotransmitter overload (especially at high dosages)
    22 KB (2,627 words) - 23:08, 29 May 2021
  • (August 1999). "Agonist-Directed Signaling of Serotonin 5-HT2C Receptors Differences Between Serotonin and Lysergic Acid Diethylamide (LSD)". Neuropsychopharmacology
    100 KB (12,100 words) - 08:20, 3 January 2024
  • Tramadol - Increased risk of serotonin syndrome. aMT - Increased risk of serotonin syndrome. MAOIs - Increased risk of serotonin syndrome. PCP - Little information
    26 KB (3,619 words) - 19:56, 7 April 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    26 KB (4,015 words) - 23:44, 21 April 2024
  • exactly how 25E-NBOH exerts its effects it is believed to act by binding to serotonin receptors in the brain. Related substances of the NBOH family include:
    17 KB (2,234 words) - 18:19, 30 April 2024
  • psychedelic drug. Bufotenin is a structural derivative of tryptamine and serotonin. Bufotenin is found in a wide array of flora and fauna, including several
    16 KB (2,273 words) - 19:54, 7 April 2024
  • Killu K (October 2008). "Serotonin reuptake inhibition by diphenhydramine and concomitant linezolid use can result in serotonin syndrome". Chest. 134 (4
    33 KB (4,164 words) - 20:42, 12 May 2024
  • can be found in many neurotransmitters, including histamine, dopamine, serotonin and noradrenaline. It is also found in many psychoactive substances, examples
    5 KB (628 words) - 23:12, 21 April 2024
  • toxicity by the serotonin 2A receptior partial agonist d-lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    27 KB (3,642 words) - 18:48, 12 November 2022
  • toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    30 KB (4,417 words) - 23:36, 21 April 2024
  • relatives to mescaline. It is thought to produce its effects by binding to serotonin receptors in the brain, although the precise mechanism is not fully understood
    13 KB (1,528 words) - 23:08, 29 May 2021
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,560 words) - 07:40, 12 October 2023
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    15 KB (2,265 words) - 06:42, 8 September 2023
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    13 KB (1,917 words) - 18:16, 30 April 2024
  • novogranatense. The mechanism of action involves increasing levels of serotonin, dopamine, and norepinephrine in the brain.[citation needed] Cocaine is
    47 KB (6,322 words) - 08:08, 3 May 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    24 KB (3,456 words) - 00:08, 3 November 2023
  • detail. Anecdotal reports have characterised 3-FEA as a moderately potent serotonin-dominant triple monoamine releaser that produces a mixture of entactogenic
    19 KB (3,317 words) - 15:23, 30 July 2022
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    21 KB (3,212 words) - 09:58, 30 May 2023
  • Tramadol - Increased risk of serotonin syndrome. aMT - Increased risk of serotonin syndrome. MAOIs - Increased risk of serotonin syndrome. PCP - Little information
    22 KB (2,938 words) - 21:31, 14 November 2023
  • substance may be a strong serotonin reuptake inhibitor (SRI). One should avoid combining MXiPr with other drugs that act on serotonin. Early anecdotal reports
    17 KB (2,265 words) - 18:27, 14 January 2024
  • additional synergistic effects. MAOIs - High risk of serotonin syndrome. SSRIs - High risk of serotonin syndrome. Antihistamines - Many H1 antagonists, including
    66 KB (8,370 words) - 12:29, 7 May 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    13 KB (2,233 words) - 00:32, 31 December 2022
  • toxicity by the serotonin 2A receptior partial agonist d-lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    67 KB (8,112 words) - 22:04, 6 May 2024
  • needed] It also blocks most of the serotonin receptors, being an inverse agonist at the 5-HT2A, 5-HT2B, and 5-HT2C serotonin receptors.[citation needed] Risperidone
    4 KB (510 words) - 11:41, 22 June 2023
  • generally recommended against. Serotonin releasers such as MDMA, 4-FA, methamphetamine, methylone and αMT will cause serotonin syndrome. If planning to combine
    19 KB (2,523 words) - 07:09, 16 November 2023
  • toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    30 KB (4,063 words) - 04:16, 30 June 2022
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    25 KB (3,654 words) - 23:46, 21 April 2024
  • ("magic mushrooms"). It is thought to produce its effects by binding to serotonin receptors in the brain. 4-HO-MET was first synthesized by the American
    24 KB (3,279 words) - 18:46, 12 November 2022
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    14 KB (2,336 words) - 23:43, 21 April 2024
  • psychedelic and stimulant effects. It produces its effects by acting on serotonin receptors in the brain. DOM was first synthesized and tested in 1963 by
    24 KB (3,112 words) - 15:32, 12 April 2023
  • Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    21 KB (3,331 words) - 23:49, 21 April 2024
  • toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    28 KB (3,658 words) - 15:27, 10 March 2023
  • Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    12 KB (2,182 words) - 23:51, 21 April 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (3,104 words) - 11:29, 16 April 2024
  • other psychedelics, it is thought to produce its effects by binding to serotonin receptors in the brain, although the precise mechanism is poorly understood
    22 KB (2,969 words) - 13:42, 16 April 2024
  • toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    23 KB (2,866 words) - 20:03, 16 December 2022
  • Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    12 KB (1,570 words) - 21:03, 19 July 2022
  • toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    36 KB (4,688 words) - 09:41, 10 May 2024
  • Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    17 KB (2,924 words) - 23:50, 21 April 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    31 KB (4,254 words) - 15:15, 6 May 2024
  • inhibit MAO-A and at the same time releasing large amounts of serotonin, effectively causing serotonin syndrome. It appears that PMMA activates the hypothalamus
    10 KB (1,254 words) - 09:30, 28 December 2022
  • Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    10 KB (2,015 words) - 23:49, 21 April 2024
  • nervous system by inhibiting the metabolism of monoamine compounds such as serotonin and norepinephrine. Harmala alkaloids are selective for MAO-A at reasonable
    13 KB (1,772 words) - 02:21, 24 September 2023
  • (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-M
    21 KB (2,634 words) - 00:21, 11 December 2023
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,604 words) - 22:15, 31 July 2022
  • agonists MAOI RIMA Modulator Piperidines Phenylpropenes Prodrugs Racetams Serotonin syndrome SSRI SNRI Synthetic cannabinoids Vagus nerve Hormone Neuron Neurotransmitter
    599 bytes (162 words) - 23:00, 21 April 2024
  • that abnormal metabolites of endogenous chemicals such as tryptamine, serotonin, and tryptophan could be the explanation for mental disorders such as schizophrenia
    14 KB (1,584 words) - 04:58, 30 June 2022
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    12 KB (1,928 words) - 23:42, 21 April 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,647 words) - 23:46, 21 April 2024
  • Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    13 KB (2,437 words) - 07:14, 27 December 2023
  • GABA, and glycine levels in various areas of the brain. It also affects serotonin in a manner which is still a matter of debate in the scientific community
    15 KB (1,935 words) - 23:24, 21 April 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    16 KB (2,465 words) - 15:45, 9 May 2024
  • as an agonist at most serotonin receptors. mCPP has been shown to act not only as a serotonin reuptake inhibitor but as a serotonin releasing agent as well
    18 KB (2,483 words) - 19:42, 10 October 2023
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,677 words) - 06:56, 28 April 2024
  • Early reports have so far characterized 3-FMA as a moderately potent serotonin-dominant triple monoamine releaser (or reuptake inhibitor) that produces
    14 KB (2,687 words) - 15:28, 30 July 2022
  • toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    35 KB (4,592 words) - 06:53, 10 December 2023
  • Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    13 KB (2,295 words) - 12:34, 29 April 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,532 words) - 22:27, 31 July 2022
  • inhibit MAO-A and at the same time releasing large amounts of serotonin, effectively causing serotonin syndrome. It appears that PMA activates the hypothalamus
    10 KB (2,183 words) - 19:02, 2 August 2022
  • psychedelics. It is regularly used in research as a radioligand to map serotonin-2A receptors in the brain.[citation needed] The effects of DOI are often
    24 KB (3,353 words) - 23:37, 21 April 2024
  • trace amine and influencer of many neurotransmitters, such as dopamine and serotonin. Phenethylamine is an important molecule in the brain, but is not often
    7 KB (919 words) - 17:25, 24 November 2023
  • psychedelics due to the unusually high selectivity it displays for various serotonin receptors. It is notable as one of the most selective agonist ligands for
    19 KB (2,640 words) - 07:18, 30 June 2022
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,561 words) - 14:02, 16 April 2024
  • and has a similar mechanism of action, acting primarily by stimulating serotonin receptors in the brain. The human use of ETH-LAD was first documented by
    29 KB (3,987 words) - 04:34, 30 June 2022
  • known, it is thought to produce its psychoactive effects by activating serotonin receptors in parts of the brain. 2C-P was first synthesized and tested
    22 KB (3,193 words) - 17:38, 18 January 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (2,675 words) - 16:54, 31 March 2024
  • increase levels of serotonin in subjects. Rather, it has been found to increase the reuptake of serotonin, being labeled a selective serotonin reuptake enhancer
    20 KB (2,399 words) - 00:17, 6 May 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    24 KB (3,701 words) - 23:42, 21 April 2024
  • Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    22 KB (3,397 words) - 23:49, 21 April 2024
  • serious adverse effects seen on overdoses of this compound (potentially Serotonin Syndrome) and as the 2,5-desmethoxy derivative of 2C-T-7 has been shown
    22 KB (2,709 words) - 23:09, 29 May 2021
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,757 words) - 17:49, 30 July 2022
  • weak serotonin reuptake inhibitor, so it is possible that combining heavy doses of efavirenz and the substances listed below may result in serotonin syndrome
    10 KB (1,224 words) - 23:39, 21 April 2024
  • has a similar mechanism of action, working primarily by binding to the serotonin-2A receptor in the brain.[citation needed] MiPLA was first discovered by
    21 KB (2,783 words) - 04:48, 30 June 2022
  • Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    7 KB (1,696 words) - 07:26, 4 December 2021
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    8 KB (1,534 words) - 19:22, 2 August 2022
  • Tramadol - Increased risk of serotonin syndrome. aMT - Increased risk of serotonin syndrome. MAOIs - Increased risk of serotonin syndrome. PCP - Little information
    16 KB (2,115 words) - 09:35, 3 September 2022
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (2,684 words) - 18:04, 30 July 2022
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    11 KB (1,914 words) - 23:46, 21 April 2024
  • LAE-32 is complex[citation needed], but it acts primarily by binding to serotonin receptors in the brain, much like LSD and other serotonergic psychedelics
    4 KB (585 words) - 07:15, 7 April 2022
  • that "Pregabalin has no involvement with serotonin and dopamine receptors and does not inhibit dopamine, serotonin, or noradrenaline reuptake." Pregabalin's
    41 KB (5,211 words) - 12:50, 15 March 2024
  • toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    26 KB (3,339 words) - 05:06, 1 July 2023
  • acts similarly to other psychedelic agents. It binds to and activates the serotonin 5-HT2A receptor with a high affinity. How activating the 5-HT2A receptor
    35 KB (3,957 words) - 06:11, 30 June 2022
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    11 KB (1,751 words) - 20:42, 12 September 2022
  • This combination may increase the amount of neurotransmitters such as serotonin and dopamine to dangerous or even fatal levels. Examples include syrian
    11 KB (1,427 words) - 22:01, 24 January 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    13 KB (2,010 words) - 00:43, 1 August 2022
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (2,776 words) - 00:39, 1 August 2022
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    9 KB (1,564 words) - 23:45, 21 April 2024
  • dopamine and norepinephrine releasing agent, with modest selectivity for serotonin. This means it effectively increases the levels of the norepinephrine and
    15 KB (2,726 words) - 11:39, 17 February 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    25 KB (3,455 words) - 23:45, 21 April 2024
  • speculated, this could indicate that 2C-T-21 is more likely to induce serotonin syndrome or general neurotransmitter overload (especially at high dosages)
    18 KB (2,002 words) - 06:06, 12 August 2022
  • are believed to come from its efficacy at the 5-HT1A and 5-HT2 family of serotonin receptors. However, the role of these interactions and how they result
    11 KB (1,523 words) - 23:37, 21 April 2024
  • in the Nucleus Accumbens. This, along with the potential increases of serotonin and other catecholamine concentrations, may be responsible for the purported
    12 KB (1,783 words) - 07:02, 29 October 2023
  • Tramadol - Increased risk of serotonin syndrome. aMT - Increased risk of serotonin syndrome. MAOIs - Increased risk of serotonin syndrome. PCP - Little information
    16 KB (2,263 words) - 23:37, 21 April 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (3,163 words) - 18:25, 30 April 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    20 KB (2,813 words) - 21:23, 25 October 2023
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    10 KB (1,757 words) - 23:45, 21 April 2024
  • psychedelics due to the unusually high selectivity it displays for various serotonin receptors. It is notable as one of the most selective agonist ligands for
    19 KB (2,736 words) - 09:31, 8 April 2024
  • dopamine, serotonin and noradrenaline. The agonism of this set of receptors results in the release of increased concentrations of dopamine, serotonin and noradrenaline
    23 KB (3,617 words) - 09:16, 17 April 2024
  • 100 g Phenethylamine Phenylalanine: 0.941 g/100 g Putrescine Salsolinol Serotonin Theobromine: 2060 mg/100 g Theophylline Tryptamine Tryptophan: 0.293 g/100
    10 KB (1,095 words) - 23:12, 9 May 2024
  • elusive. It is the 4O-allyl homolog of mescaline, and binds similarly to the serotonin receptors. It seems to have considerably increased potency by weight, with
    10 KB (1,076 words) - 12:09, 2 May 2022
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,584 words) - 12:23, 5 April 2024
  • effect of dichloropane on the central nervous system is the blockade of the serotonin, dopamine, and norepinephrine transporter. This substance acts as a triple
    20 KB (2,747 words) - 00:19, 1 August 2022
  • playing only a minor role in a scientific study as a precursor of 5-HT2A serotonin receptor agonists. The next confirmed mention of the substance can be dated
    13 KB (1,619 words) - 06:10, 30 June 2022
  • toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    22 KB (3,030 words) - 21:29, 14 November 2023
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    14 KB (2,109 words) - 23:22, 21 April 2024
  • MAO-altering effects, this could indicate that 2C-B-FLY is more likely to induce serotonin syndrome or general monoamine overload (especially at high dosages) than
    21 KB (2,764 words) - 23:36, 21 April 2024
  • on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,503 words) - 00:26, 6 May 2024
  • activity at the 5-HT2A serotonin receptor. Bromo-DragonFLY also has a high binding affinity for the 5-HT2B and 5-HT2C serotonin receptors, and is most
    20 KB (2,786 words) - 23:37, 21 April 2024
  • Bromantane is atypical among stimulants in the sense that it inhibits serotonin reuptake in addition to inhibiting dopamine reuptake. It also increases
    14 KB (1,794 words) - 23:23, 21 April 2024
  • psychedelic tryptamines have a very strong structural similarities to serotonin itself, which partially explains the affinity for certain 5-HT sites. It
    9 KB (1,156 words) - 05:07, 30 June 2022
  • antagonist MXE acts as a non-competitive NMDA receptor antagonist and serotonin-reuptake inhibitor. NMDA receptors allow for electrical signals to pass
    23 KB (2,917 words) - 00:54, 19 September 2023
  • information: Serotonergic psychedelic Escaline's agonist activity at the serotonin 5-HT2A receptor is known to be 5-8 times greater than that of mescaline
    12 KB (1,512 words) - 00:01, 21 December 2023
  • OCLC 1166889264.  Nichols, D. E.; Dyer, D. C. (1977). "Lipophilicity and serotonin agonist activity in a series of 4-substituted mescaline analogs". Journal
    10 KB (1,076 words) - 21:01, 29 May 2021
  • chemicals such as acetylcholine, norepinephrine, dopamine, beta-endorphin and serotonin in the brain and other parts of the body. After sustained use, though,
    53 KB (5,335 words) - 06:57, 15 May 2024
  • diphenidine have stated the compound acts as a dopamine-reuptake inhibitor and a serotonin reuptake inhibitor with µ-opioid affinity and typical dissociative effects
    20 KB (2,560 words) - 20:28, 17 January 2024
  • mechanism from the subsequent activation of 5-HT2B, which is an effect of serotonin-related valvulopathy. Amphetamines generally cause hypertension in models
    5 KB (1,411 words) - 18:49, 5 May 2024
  • toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    31 KB (4,078 words) - 22:48, 15 April 2023
  • the other major neurotransmitters, including dopamine, acetylcholine, serotonin, and, in high doses, on norepinephrine, and to a small extent epinephrine
    29 KB (3,603 words) - 00:00, 10 May 2024
  • (December 2005). "Differential phospholipase C activation by phenylalkylamine serotonin 5-HT2A receptor agonists". Journal of Neurochemistry. 95 (6): 1575–1584
    21 KB (2,972 words) - 17:25, 26 January 2023
  • other psychedelics due to the unusually high selectivity it displays for serotonin receptors. It is notable as one of the most selective agonist ligands for
    19 KB (2,665 words) - 20:05, 19 July 2022
  • clinically negligible anticholinergic properties. Quetiapine binds strongly to serotonin receptors; the drug acts as partial agonist at 5-HT1A receptors. In terms
    26 KB (3,070 words) - 00:36, 28 April 2024
  • "Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents". Pharmacology Biochemistry and
    22 KB (2,679 words) - 15:39, 28 January 2023
  • the other major neurotransmitters, including dopamine, acetylcholine, serotonin, and, in high doses, norepinephrine, and to a small extent epinephrine
    10 KB (1,245 words) - 19:38, 30 April 2024
  • mechanism from the subsequent activation of 5-HT2B, which is an effect of serotonin-related valvulopathy. Amphetamines generally cause hypertension in models
    17 KB (2,934 words) - 17:24, 18 January 2024
  • benzodiazepines, with similar effects on locomotor activity and on dopamine and serotonin turnover. In comparison to other substances of a similar nature such as
    16 KB (2,144 words) - 01:23, 20 April 2024
  • nootropic effects. The involvement of SAM-e in the process of synthesizing serotonin, creatine and dopamine likely play a role in nootropic effects as well
    10 KB (1,304 words) - 23:24, 21 April 2024
  • ISSN 0306-5251.  Laborit, H. (January 1972). "Correlations between protein and serotonin synthesis during various activities of the central nervous system (slow
    35 KB (4,460 words) - 13:32, 16 April 2024
  • action is believed to result from its partial agonism of 5-HT2A and 5-HT1A serotonin receptors. Disclaimer: The effects listed below cite the Subjective Effect
    23 KB (3,192 words) - 12:43, 2 May 2022
  • mechanism from the subsequent activation of 5-HT2B, which is an effect of serotonin-related valvulopathy. Amphetamines generally cause hypertension in models
    17 KB (3,024 words) - 17:25, 18 January 2024
  • trigger seizures in susceptible individuals.[citation needed] Selective serotonin reuptake inhibitors (SSRIs) - SSRIs are reported to suppress the visual
    29 KB (3,883 words) - 13:23, 16 April 2024
  • the norepinephrine and serotonin receptor systems where it functions as an agonist. Its action on norepinephrine and serotonin also likely contributes
    42 KB (6,087 words) - 13:21, 16 April 2024
  • subanesthetic and fully anesthetic doses, ketamine has been found to block serotonin depletion in the brain by inhibiting 5-HT receptors rather than through
    57 KB (7,569 words) - 21:34, 6 May 2024
  • metabolized in the human body into noribogaine. Noribogaine acts as a serotonin reuptake inhibitor. It also acts as a moderate κ-opioid receptor agonist
    28 KB (3,126 words) - 11:42, 16 April 2024
  • Template health overview (category PsychonautWiki)
    ergic psychedelic Serotonin Serotonin/Summary Template:SubstanceBox/Serotonin Serotonin-norepinephrine reuptake inhibitor Serotonin-norepinephrine reuptake
    1 KB (0 words) - 21:34, 18 January 2022
  • types of antidepressants can cause adverse effects as well as possible serotonin syndrome when mixed. Mirtazapine is legally approved for medical purposes
    32 KB (3,698 words) - 18:07, 7 April 2024
  • Psychonaut media index (category PsychonautWiki)
    Stimulants Amphetamine Caffeine Cocaine Nicotine Other Dopamine Oxytocin Serotonin Serotonin Reuptake Inhibitors (SSRIs) The Infographics Show Cocaine vs Heroin
    70 KB (2,463 words) - 23:01, 21 April 2024
  • µ-opioid receptors, inhibits synaptosomal uptake of noradrenaline, dopamine, serotonin and gamma-aminobutyric acid (GABA), and cellular uptake of anandamide,
    23 KB (2,978 words) - 07:22, 8 April 2023
  • List of articles (category PsychonautWiki)
    Norepinephrine (Noradrenaline) Serotonin (5-HT) Catecholamines Dopamine Phenethylamines Phenethylamine Tryptamine Serotonin (5-HT) BPC-157 Cerebrolysin Dihexa
    502 bytes (5,908 words) - 20:25, 10 June 2017
  • ignore a general slightly unpleasant serotonin wooziness. Subject slept for a few hours; when he rose the serotonin sickness had completely subsided and
    10 KB (1,597 words) - 23:53, 22 March 2022
  • A. (March 2013). "Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT 2A ) receptor activity via ERK1/2 signaling". Synapse. 67 (3):
    65 KB (8,816 words) - 18:09, 27 April 2024
  • and subjective effects. 1D-AL-LAD acts primarily as a partial agonist at serotonin receptors in the brain, particularly the 5-HT2A receptor. This mechanism
    3 KB (323 words) - 01:26, 6 May 2024
  • Examples of neurotransmitters: Glutamate GABA Acetylcholine Dopamine Serotonin Noradrenaline Endogenousopioids (mostly rather neuromodulatory function)
    8 KB (1,200 words) - 14:53, 22 November 2023
  • Diphenhydramine has been shown to block sodium channels and inhibit the reuptake of serotonin. It also blocks voltage-gated potassium channels (VGKCs), meaning it has
    11 KB (1,908 words) - 00:03, 3 March 2024